SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-18-007923
Filing Date
2018-08-13
Accepted
2018-08-13 16:20:33
Documents
57
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q s111760_10q.htm 10-Q 290776
2 EXHIBIT 31.1 s111760_ex31-1.htm EX-31.1 8441
3 EXHIBIT 31.2 s111760_ex31-2.htm EX-31.2 8462
4 EXHIBIT 32.1 s111760_ex32-1.htm EX-32.1 3905
5 EXHIBIT 32.2 s111760_ex32-2.htm EX-32.2 3865
  Complete submission text file 0001615774-18-007923.txt   2389555

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE atos-20180630.xml EX-101.INS 422822
7 XBRL SCHEMA FILE atos-20180630.xsd EX-101.SCH 30030
8 XBRL CALCULATION FILE atos-20180630_cal.xml EX-101.CAL 44800
9 XBRL DEFINITION FILE atos-20180630_def.xml EX-101.DEF 85582
10 XBRL LABEL FILE atos-20180630_lab.xml EX-101.LAB 232213
11 XBRL PRESENTATION FILE atos-20180630_pre.xml EX-101.PRE 180852
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35610 | Film No.: 181012489
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1